Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Therapeutic spectrum of interferon‐β in ischemic stroke
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Therapeutic spectrum of interferon‐β in ischemic stroke
Creator
Sarmah, Deepaneeta
Borah, Anupom
Kaur, Harpreet
Saraf, Jackson
Wanve, Madhuri
Dave, R
Dileep, |
Kanchan Vats, |
Kanta Pravalika, |
Kiran Kalia, |
Kunjan, |
Pallab Bhattacharya, |
Yavagal, R
source
PMC
abstract
Ischemic stroke is devastating and a major cause of morbidity and mortality worldwide. To date, only clot retrieval devices and/or intravenous tissue plasminogen activators (tPA) have been approved by the US‐FDA for the treatment of acute ischemic stroke. Therefore, there is an urgent need to develop an effective treatment for stroke that can have limited shortcomings and broad spectrum of applications. Interferon‐beta (IFN‐β), an endogenous cytokine and a key anti‐inflammatory agent, contributes toward obviating deleterious stroke outcomes. Therefore, exploring the role of IFN‐β may be a promising alternative approach for stroke intervention in the future. In the present review, we have discussed about IFN‐β along with its different mechanistic roles in ischemic stroke. Furthermore, therapeutic approaches targeting the inflammatory cascade with IFN‐β therapy that may be helpful in improving stroke outcome are also discussed.
has issue date
2018-10-15
(
xsd:dateTime
)
bibo:doi
10.1002/jnr.24333
bibo:pmid
30320448
has license
no-cc
sha1sum (hex)
d7ed6431a806223fc332551cd6b85c14b9bb0197
schema:url
https://doi.org/10.1002/jnr.24333
resource representing a document's title
Therapeutic spectrum of interferon‐β in ischemic stroke
has PubMed Central identifier
PMC7167007
has PubMed identifier
30320448
schema:publication
J Neurosci Res
resource representing a document's body
covid:d7ed6431a806223fc332551cd6b85c14b9bb0197#body_text
is
schema:about
of
named entity 'MORBIDITY AND MORTALITY'
named entity 'ISCHEMIC STROKE'
named entity 'CAUSE'
named entity 'EFFECTIVE'
named entity 'NEED'
named entity 'LIMITED'
named entity 'DATE'
named entity 'Ischemic stroke'
named entity 'stroke'
named entity 'broad spectrum'
named entity 'morbidity'
named entity 'US-FDA'
named entity 'ischemic stroke'
named entity 'headache'
named entity 'BBB'
named entity 'permeability'
named entity 'stroke'
named entity 'protein'
named entity 'Interferon-β'
named entity 'innate immunity'
named entity 'inflammatory conditions'
named entity 'Harvard Medical School'
named entity 'chemokine'
named entity 'Depression'
named entity 'Cerebral ischemic injury'
named entity 'nitric oxide'
named entity 'caspases'
named entity 'inhibitor of apoptosis'
named entity 'chemokine'
named entity 'adhesion molecules'
named entity 'dramatic increase'
named entity 'ischemic'
named entity 'microvascular injury'
named entity 'neutrophils'
named entity 'IL-1B'
named entity 'colorectal cancer'
named entity 'DNA sequence'
named entity 'neuroinflammation'
named entity 'reperfusion'
named entity 'ischemic injury'
named entity 'allergic diseases'
named entity 'dendritic cells'
named entity 'transmembrane receptor'
named entity 'inflammatory cells'
named entity 'reperfusion'
named entity 'multiple sclerosis'
named entity 'monocytes'
named entity 'B-cell lymphoma 2'
named entity 'immunomodulatory'
named entity 'macrophages'
named entity 'cerebral ischemia'
named entity 'myalgia'
named entity 'TNF-related apoptosis-inducing ligand'
named entity 'contralateral'
named entity 'Interferon'
named entity 'E-selectin'
named entity 'blood vessels'
named entity 'ischemia'
named entity 'inflammatory cytokines'
named entity 'endothelial'
named entity 'excitotoxicity'
named entity 'Ischemic injury'
named entity 'pro-apoptotic'
named entity 'neurons'
named entity 'neurodegeneration'
named entity 'IFNAR'
named entity 'IFN-β'
named entity 'stroke'
named entity 'anti-inflammatory agent'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 7
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software